IL107881A0 - Furanone derivatives and pharmaceutical compositions containing them - Google Patents

Furanone derivatives and pharmaceutical compositions containing them

Info

Publication number
IL107881A0
IL107881A0 IL10788193A IL10788193A IL107881A0 IL 107881 A0 IL107881 A0 IL 107881A0 IL 10788193 A IL10788193 A IL 10788193A IL 10788193 A IL10788193 A IL 10788193A IL 107881 A0 IL107881 A0 IL 107881A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
furanone derivatives
furanone
derivatives
Prior art date
Application number
IL10788193A
Original Assignee
Fisons Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929225497A external-priority patent/GB9225497D0/en
Priority claimed from GB929225498A external-priority patent/GB9225498D0/en
Priority claimed from GB939316531A external-priority patent/GB9316531D0/en
Application filed by Fisons Corp filed Critical Fisons Corp
Publication of IL107881A0 publication Critical patent/IL107881A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL10788193A 1992-12-05 1993-12-05 Furanone derivatives and pharmaceutical compositions containing them IL107881A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929225497A GB9225497D0 (en) 1992-12-05 1992-12-05 Pharmacologically active compounds
GB929225498A GB9225498D0 (en) 1992-12-05 1992-12-05 Pharmacologically active compounds
GB939316531A GB9316531D0 (en) 1993-08-10 1993-08-10 Pharmacologically active compounds

Publications (1)

Publication Number Publication Date
IL107881A0 true IL107881A0 (en) 1994-04-12

Family

ID=27266497

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10788193A IL107881A0 (en) 1992-12-05 1993-12-05 Furanone derivatives and pharmaceutical compositions containing them

Country Status (10)

Country Link
EP (1) EP0672046A1 (en)
JP (1) JPH08503955A (en)
KR (1) KR950704322A (en)
AU (1) AU5655394A (en)
CA (1) CA2150947A1 (en)
FI (1) FI952733A0 (en)
IL (1) IL107881A0 (en)
MX (1) MX9307679A (en)
NO (1) NO952194D0 (en)
WO (1) WO1994013678A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL129793A (en) * 1997-01-27 2003-01-12 Warner Lambert Co Process for producing (z)-azabicyclo oxime ethers
TWI243173B (en) 1999-11-17 2005-11-11 Akzo Nobel Nv Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
ES2295963T3 (en) 2004-01-08 2008-04-16 F. Hoffmann-La Roche Ag DIAZA-SPIROPIPERIDINE DERIVATIVES AS INHIBITORS OF GLICINE TRANSPORTER 1 AND GLICINE TRANSPORTER 2.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075317A (en) * 1989-06-21 1991-12-24 Fisons Corporation Spirofurane derivatives
JPH03153690A (en) * 1989-11-10 1991-07-01 Yamanouchi Pharmaceut Co Ltd Heterocyclic spiro derivative and production thereof
IE914238A1 (en) * 1990-12-19 1992-07-01 Fisons Corp Novel spirofurane derivatives

Also Published As

Publication number Publication date
MX9307679A (en) 1994-06-30
NO952194L (en) 1995-06-02
CA2150947A1 (en) 1994-06-23
WO1994013678A1 (en) 1994-06-23
AU5655394A (en) 1994-07-04
JPH08503955A (en) 1996-04-30
KR950704322A (en) 1995-11-17
FI952733A (en) 1995-06-05
NO952194D0 (en) 1995-06-02
EP0672046A1 (en) 1995-09-20
FI952733A0 (en) 1995-06-05

Similar Documents

Publication Publication Date Title
IL111221A0 (en) N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them
IL106431A0 (en) Aminediol derivatives and pharmaceutical compositions containing the same
IL105218A0 (en) Hexanones and pharmaceutical compositions containing them
IL105223A0 (en) Cyclohexane-ylidenes and pharmaceutical compositions containing them
IL105220A0 (en) Cyclohexanylidene compounds and pharmaceutical compositions containing them
ZA937321B (en) Taxol derivatives their preparation and compositions containing them
IL105221A0 (en) Cyclohexane derivatives and pharmaceutical compositions containing them
ZA94342B (en) C2 Taxane derivatives and pharmaceutical compositions containing them
IL105003A0 (en) Indole derivatives and pharmaceutical compositions containing them
IL104824A0 (en) Heterobicyclic compounds and pharmaceutical compositions containing them
IL88988A0 (en) Didehydro-vitamin d3 derivatives and pharmaceutical compositions containing them
IL103910A0 (en) New peptide derivatives and pharmaceutical compositions containing them
IL116851A (en) 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them
NZ244766A (en) Bi-aromatic compounds and pharmaceutical compositions
IL106141A0 (en) Thiazolylvinylphenyl derivatives,their manufacture and pharmaceutical compositions containing them
GB2271059B (en) Pharmaceutical compositions comprising aconitane derivatives and tetrahydroprotoberberine derivatives.
IL106098A0 (en) Heteroarylnaphthalenes and pharmaceutical compositions containing them
IL105673A0 (en) Purine derivatives and pharmaceutical compositions containing them
IL105672A0 (en) Substituted adenosine derivatives and pharmaceutical compositions containing them
IL108073A0 (en) Substituted 6-azaandrostenones their preparation and pharmaceutical compositions containing them
IL107627A0 (en) Benzopyran derivatives their preparation and pharmaceutical compositions containing them
IL100850A0 (en) Indole derivatives and pharmaceutical compositions containing them
IL102178A0 (en) Chroman derivatives and pharmaceutical compositions containing them
HUT67287A (en) Piperazynil camphor derivatives and pharmaceutical compositions containing them
ZA948689B (en) New taxicin derivatives their preparation and pharmaceutical compositions containing them